Phaeochromocytoma is a catecholamine-secreting tumour associated with clinical presentation ranging from paroxysmal hypertension to intractable cardiogenic shock. Extracorporeal life support, in veno-arterial mode, application in refractory acute heart dysfunction is sharply increasing worldwide. However, its clinical utility in phaeochromocytoma-induced cardiogenic shock remains still unclear.
Methods:
A systematic review of published reports was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Statement. Searches were accomplished on PubMed, Embase and Google Scholar to identify articles describing the use of extracorporeal life support in the setting of phaeochromocytoma-induced cardiogenic shock (PROSPERO: CRD42019125225).
Results:
Thirty-five reports, including 62 patients supported with extracorporeal life support because of intractable phaeochromocytoma crisis, were included for the analysis. Almost all the subjects underwent peripheral cannulation for extracorporeal life support. The median duration of the mechanical circulatory support was 5 days, and most of the patients recovered normal myocardial function (left ventricular ejection fraction ⩾50%). In-hospital survival was 87%. Phaeochromocytoma was removed surgically during extracorporeal life support in 10 patients (16%), while in the remaining after haemodynamic stabilization and weaning from the mechanical support.
Conclusion:
Successful management of phaeochromocytoma-induced cardiogenic shock depends on prompt recognition and immediate treatment of shock. In this scenario, extracorporeal life support may play a significant role allowing cardiac and end-organ recovery and giving time for accurate diagnosis and specific treatment.
CohenCDDentDM. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgrad Med J1984; 60: 111–115.
2.
De WildeDVelkeniersBHuyghensL, et al. The paradox of hypotension and pheochromocytoma: a case report. Eur J Emerg Med2004; 11: 237–239.
3.
LawlerPRSilverDASciricaBM, et al. Extracorporeal membrane oxygenation in adults with cardiogenic shock. Circulation2015; 131: 676–680.
4.
CombesALeprincePLuytCE, et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med2008; 36: 1404–1411.
5.
PagesONAubertSCombesA, et al. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation-extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg2009; 137: 194–197.
6.
MullerGFlecherELebretonG, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med2016; 42: 370–378.
7.
ChenSWTsaiFCLinYS, et al. Long-term outcomes of extracorporeal membrane oxygenation support for postcardiotomy shock. J Thorac Cardiovasc Surg2017; 154: 469–477.e2.
8.
SchmidtMZogheibERozéH, et al. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med2013; 39: 1704–1713.
9.
BaudFJMegarbaneBDeyeN, et al. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care2007; 11: 207.
10.
LorussoRCentofantiPGelsominoS, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg2016; 101: 919–926.
11.
TakagiSMiyazakiSFujiiT, et al. Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn Circ J2000; 64: 785–788.
12.
GrindaJMBricourtMOSalviS, et al. Unusual cardiogenic shock due to pheochromocytoma: recovery after bridge-to-bridge (extracorporeal life support and DeBakey ventricular assist device) and right surrenalectomy. J Thorac Cardiovasc Surg2006; 131: 913–914.
13.
KimHSChangWIKimYC, et al. Catecholamine cardiomyopathy associated with paraganglioma rescued by percutaneous cardiopulmonary support: inverted takotsubo contractile pattern. Circ J2007; 71: 1993–1995.
14.
MoherDLiberatiATetzlaffJ, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 21: e1000097.
15.
ChaoAYehYCYenTS, et al. Phaeochromocytoma crisis-a rare indication for extracorporeal membrane oxygenation. Anaesthesia2008; 63: 86–88.
16.
GrasselliGFotiGPatronitiN, et al. Extracorporeal cardiopulmonary support for cardiogenic shock caused by pheochromocytoma: a case report and literature review. Anesthesiology2008; 108: 959–962.
17.
HuangJHHuangSCChouNK, et al. Extracorporeal membrane oxygenation rescue for cardiopulmonary collapse secondary to pheochromocytoma: report of three cases. Intensive Care Med2008; 34: 1551–1552.
18.
NewtonJDMunirSBhindiR, et al. What a headache: rare neuroendocrine indication for cardiopulmonary bypass for severe left ventricular dysfunction and shock. Circ Heart Fail2008; 1: 143–145.
19.
SuhIWLeeCWKimYH, et al. Catastrophic catecholamine-induced cardiomyopathy mimicking acute myocardial infarction, rescued by extracorporeal membrane oxygenation (ECMO) in pheochromocytoma. J Korean Med Sci2008; 23: 350–354.
20.
WuXMChenJJWuCK, et al. Pheochromocytoma presenting as acute myocarditis with cardiogenic shock in two cases. Intern Med2008; 47: 2151–2155.
21.
ZegdiRParisotCSleilatyG, et al. Pheochromocytoma-induced inverted takotsubo cardiomyopathy: a case of patient resuscitation with extracorporeal life support. J Thorac Cardiovasc Surg2008; 135: 434–435.
22.
EzriTGolanASassonL, et al. Pheochromocytoma induced fulminant cardiogenic shock following laparoscopic salpingectomy, successfully managed with extracorporeal membrane oxygenation. J Rom Anest Terap Int2009; 16: 154–158.
23.
ParkSMKimDHKwakYT, et al. Pheochromocytoma-induced cardiogenic shock rescued by percutaneous cardiopulmonary bypass system. Circ J2009; 73: 1753–1755.
24.
NakajimaYMasaokaNSodeyamaM, et al. Pheochromocytoma-related cardiomyopathy during the antepartum period in a preterm pregnant woman. J Obstet Gynaecol Res2011; 37: 908–911.
25.
RitterSGuertlerTMeierCA, et al. Cardiogenic shock due to pheochromocytoma rescued by extracorporeal membrane oxygenation. Interact Cardiovasc Thorac Surg2011; 13: 112–113.
26.
BanfiCJuthierFEnnezatPV, et al. Central extracorporeal life support in pheochromocytoma crisis. Ann Thorac Surg2012; 93: 1303–1305.
27.
NooraniAVuylstekeALewisC, et al. A moribund athlete. Lancet2012; 380: 74.
28.
SheinbergRGaoWDWandG, et al. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth2012; 26: 161–165.
29.
StegPGJamesSKAtarD, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J2012; 33: 2569–2619.
30.
KaeseSSchulkeCFischerD, et al. Pheochromocytoma-induced takotsubo-like cardiomyopathy and global heart failure with need for extracorporal life support. Intensive Care Med2013; 39: 1473–1474.
31.
LawCKhaliqAGuglinM. Reversible cardiogenic shock due to catecholamine-induced cardiomyopathy: a variant of takotsubo?Am J Emerg Med2013; 31: 1621.e1–1621.e3.
32.
ChaoAWangCHYouHC, et al. Highlighting indication of extracorporeal membrane oxygenation in endocrine emergencies. Sci Rep2015; 5: 13361.
33.
FlamBBroomeMFrencknerB, et al. Pheochromocytoma-induced inverted takotsubo-like cardiomyopathy leading to cardiogenic shock successfully treated with extracorporeal membrane oxygenation. J Intensive Care Med2015; 30: 365–372.
34.
RiesterAWeismannDQuinklerM, et al. Life-threatening events in patients with pheochromocytoma. Eur J Endocrinol2015; 173: 757–764.
35.
SpangenbergTFrekerCNiggemannC, et al. Differential diagnosis of a fulminant myocarditis: the pheochromocytoma crisis. Eur Heart J Acute Cardiovasc Care2015; 4: 577–578.
36.
VagnerHHeyTMElleB, et al. Embolisation of pheochromocytoma to stabilise and wean a patient in cardiogenic shock from emergency extracorporeal life support. BMJ Case Rep. Epub ahead of print 3March2015. DOI: 10.1136/bcr-2014-206069.
37.
ZhouXLiuDSuL, et al. Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report. Medicine2015; 94: e790.
38.
Dang VanSHamyAHubertN, et al. Cardiogenic shock induced by a voluminous phaeochromocytoma rescued by concomitant extracorporeal life support and open left adrenalectomy. Eur J Cardiothorac Surg2016; 50: 782–783.
39.
HekimianGKharchaFBréchotN, et al. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care2016; 6: 117.
40.
KodamaTAgozzinoMPellegriniC, et al. Endomyocardial biopsy in acute cardiogenic shock: diagnosis of pheochromocytoma. Int J Cardiol2016; 202: 897–899.
41.
Van ZwetCJRistAHaeusslerA, et al. Extracorporeal membrane oxygenation for treatment of acute inverted Takotsubo-like cardiomyopathy from hemorrhagic pheochromocytoma in late pregnancy. A A Case Rep2016; 7: 196–199.
42.
BouabdallaouiNBouchardDJolicoeurEM, et al. Extracorporeal membrane oxygenation in pheochromocytoma-induced cardiogenic shock. Asian Cardiovasc Thorac Ann2018; 26: 314–316.
43.
FungRKArumugamDTjokrowidjajaA, et al. Veno-arterial extracorporeal membrane oxygenation for severe cardiogenic shock secondary to phaeochromocytoma crisis. Anaesth Intensive Care2017; 45: 635–637.
44.
MitaKTsugitaKYasudaY, et al. A successfully treated case of cardiac arrest after Caesarean section complicated by pheochromocytoma crisis and amniotic fluid embolism. J Anesth2017; 31: 140–143.
45.
SauneufBChudeauNChampigneulleB, et al. Pheochromocytoma crisis in the ICU: a french multicenter cohort study with emphasis on rescue extracorporeal membrane oxygenation. Crit Care Med2017; 45: e657–e665.
46.
Martin-VillenLCorcia-PalomoYEscalona-RodriguezS, et al. Extracorporeal membrane oxygenation support in a patient with pheochromocytoma stress myocardiopathy. Med Intensiva2018; 42: 566–568.
47.
LendersJWEisenhoferGMannelliM, et al. Phaeochromocytoma. Lancet2005; 366: 665–675.
48.
KizerJRKoniarisLSEdelmanJD, et al. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest2000; 118: 1221–1223.
49.
MohamedHAAldakarMOHabibN. Cardiogenic shock due to acute hemorrhagic necrosis of a pheochromocytoma: a case report and review of the literature. Can J Cardiol2003; 19: 573–576.
50.
ScholtenACiscoRMVriensMR, et al. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab2013; 98: 581–591.
51.
OlsonSWDealLEPiesmanM. Epinephrine-secreting pheochromocytoma presenting with cardiogenic shock and profound hypocalcemia. Ann Intern Med2004; 140: 849–851.
SimonsMDowningSE. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J1985; 109: 297–304.
54.
GuzikPWykretowiczAWesselingIK, et al. Adrenal pheochromocytoma associated with dramatic cyclic hemodynamic fluctuations. Int J Cardiol2005; 103: 351–353.
55.
PacakKEisenhoferGIliasI. Diagnostic imaging of pheochromocytoma. Front Horm Res2004; 31: 107–120.
56.
WuGYDoshiAAHaasGJ. Pheochromocytoma induced cardiogenic shock with rapid recovery of ventricular function. Eur J Heart Fail2007; 9: 212–214.
57.
ZangrilloALandoniGBiondi-ZoccaiG, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc2013; 15: 172–178.
58.
MeaniPGelsominoSNatourE, et al. Modalities and effects of left ventricle unloading on extracorporeal life support: a review of the current literature. Eur J Heart Fail2017; 19: 84–91.
59.
SojodGDianaMWallJ, et al. Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure. Am J Emerg Med2012; 30: 1017.e1–1017.e3.
60.
LentschenerCGaujouxSTesniereA, et al. Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal. Eur J Endocrinol2011; 165: 365–373.
61.
AbramsDGaranARAbdelbaryA, et al. International ECMO Network (ECMONet) and The Extracorporeal Life Support Organization (ELSO): position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med2018; 44: 717–729.
